MY192792A - A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof - Google Patents

A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof

Info

Publication number
MY192792A
MY192792A MYPI2019001207A MYPI2019001207A MY192792A MY 192792 A MY192792 A MY 192792A MY PI2019001207 A MYPI2019001207 A MY PI2019001207A MY PI2019001207 A MYPI2019001207 A MY PI2019001207A MY 192792 A MY192792 A MY 192792A
Authority
MY
Malaysia
Prior art keywords
carrier protein
capsular polysaccharide
composition
protein conjugates
pneumococcal capsular
Prior art date
Application number
MYPI2019001207A
Inventor
Tae Hyun Kim
Hoon Sung Jeh
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of MY192792A publication Critical patent/MY192792A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a vaccine composition for preventing pneumococcal diseases and an immunogenic composition against Streptococcus pneumoniae, which contains 13 or 14 types of capsular polysaccharide-carrier protein conjugates.
MYPI2019001207A 2016-09-06 2017-08-31 A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof MY192792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (en) 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Publications (1)

Publication Number Publication Date
MY192792A true MY192792A (en) 2022-09-09

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019001207A MY192792A (en) 2016-09-06 2017-08-31 A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof

Country Status (12)

Country Link
KR (1) KR101991457B1 (en)
BR (1) BR112019004303A2 (en)
EA (1) EA201990451A1 (en)
JO (1) JOP20190038B1 (en)
MA (1) MA45283B1 (en)
MX (1) MX2019002552A (en)
MY (1) MY192792A (en)
PH (1) PH12019500377A1 (en)
SA (1) SA519401232B1 (en)
TN (1) TN2019000064A1 (en)
WO (1) WO2018048141A1 (en)
ZA (1) ZA201901969B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019139692A2 (en) 2017-12-06 2019-07-18 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
CA3089007A1 (en) 2018-02-05 2019-08-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019256218A1 (en) 2018-04-18 2020-12-03 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
MX2021007496A (en) 2018-12-19 2021-08-05 Merck Sharp & Dohme Llc Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof.
WO2023218322A1 (en) * 2022-05-11 2023-11-16 Pfizer Inc. Process for producing of vaccine formulations with preservatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3828145B2 (en) * 1993-09-22 2006-10-04 ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン A method for the activation of soluble carbohydrates using a novel cyanating reagent for the production of immunogenic components
EP2425854A1 (en) * 2005-04-08 2012-03-07 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
CN107080838A (en) * 2010-06-04 2017-08-22 惠氏有限责任公司 Bacterin preparation
KR102057217B1 (en) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
CN103893751B (en) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 A kind of pneumococal polysaccharide Protein Conjugation vaccine and preparation method thereof
CN104069504B (en) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 A method of enhancing polysaccharide protein conjugate immunogenicity

Also Published As

Publication number Publication date
EA201990451A1 (en) 2019-08-30
JOP20190038A1 (en) 2019-03-06
KR20180027353A (en) 2018-03-14
PH12019500377A1 (en) 2019-10-21
JOP20190038B1 (en) 2023-09-17
MA45283B1 (en) 2021-05-31
MX2019002552A (en) 2019-07-01
WO2018048141A1 (en) 2018-03-15
MA45283A1 (en) 2019-06-28
SA519401232B1 (en) 2022-10-23
ZA201901969B (en) 2019-12-18
TN2019000064A1 (en) 2020-07-15
BR112019004303A2 (en) 2019-05-28
KR101991457B1 (en) 2019-09-30

Similar Documents

Publication Publication Date Title
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
IL297575B1 (en) Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
JOP20190038B1 (en) A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof
MX2016009468A (en) Streptococcus pneumoniae capsular polysaccharides and conjugates thereof.
PH12018500037A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2022009928A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
EP3668541A4 (en) Pneumococcal conjugate vaccine formulations
EP3585803A4 (en) Pneumococcal conjugate vaccine formulations
MX2017009308A (en) Immunogenic compositions for use in pneumococcal vaccines.
MX2020001138A (en) Streptococcus pneumoniae capsular polysaccharides and conjugates thereof.
MX2019008564A (en) Immunogenic compositions for use in pneumococcal vaccines.
MX2021014948A (en) METHODS OF TREATING PATIENTS WITH AN IMMUNOGENIC COMPOSITION THAT PROTECTS AGAINST <i>S. PNEUMONIAE</i> SEROTYPE 29.
MX2016003621A (en) Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3.
IL276661A (en) Immunogenic composition comprising staphylococcal antigens
EP3863667A4 (en) Multivalent pneumococcal polysaccharide-protein conjugate vaccine
MX2019013779A (en) Vaccine comprising clostridium toxoids.
TH1701007335A (en) Methods for improving the absorption of conjugated polysaccharide-protein and multivalent vaccine formulations were derived from them.